[0] https://www.astrazeneca.com/media-centre/press-releases/2020...
[0] https://www.astrazeneca.com/media-centre/press-releases/2020...
That's not what the Oxford/AZ vaccine does, is it? From what I understand, it's a viral vector vaccine engineered to deliver DNA that encodes the SARS-CoV-2 spike protein into human cells and induce them to express the protein, stimulating the immune response.
The plan was never to introduce spike protein "produced outside the body." The mechanism of action is getting the body to produce spike protein and learn to attack it as foreign. If the Oxford/AZ vaccine doesn't "take advantage of your own cells to produce the spike protein," I don't know what does.
https://labblog.uofmhealth.org/rounds/top-5-covid-19-vaccine...
There are still other attenuated virus and other vaccines under development, they just haven't reached Phase III. Novavax even does something similar to what you describe (spike proteins with adjuvant), but it's also not past Phase I/II.
With that, a misfire can happen with any vaccine attempt, because an immune response is what's required.
Yes. It uses a live (weakened) chimpanzee adenovirus to insert the spike protein.
Wow nature is truly a marvel! How do they do that? Or where could I read more?
Read about the HLA/MHC class I pathway. And also about JAK/STAT1, which is how cells decide if they are infected.
Virus enters body, hopefully survives immune system long enough to insert instructions into your cells, your cells churn out tons of copies of coronavirus spike protein, your immune system sees the surfeit of spike protein and develops a response (antibodies and T* cells).
https://blogs.sciencemag.org/pipeline/archives/2020/04/23/a-...
The immune system is a "complicated" thing to work with.
My favorite dad quip was 'Biology itself is proof against an intelligent designer.'
Evolution isn't going to nicely separate functionality into clean, single-purpose biochemical pathways.
It's going to overload something that it already has to support a new feature, leading to a rat's nest of intertwined effects.
The hard part in drug development isn't affecting your target: that's pretty easy to guarantee with modern tools. It's finding out that that target also governs 10 other, completely unrelated bodily functions.
Some companies in the valley just call that Wednesday.=)
Did you mean integration testing?
Evolution unit tests, then integrates in prod.
That's a great analogy, except it doesn't go quite far enough. The code for the toolchain that compiles the codebase (not to mention the unit testing framework) is just as old, and written the same way.
Your body basically is trying to do a sort of brute force/random combination of immune cells on the retrieved virus spike proteins until it comes up with the right combination.
https://en.wikipedia.org/wiki/Somatic_hypermutation
This process can result in B cells that produce antibodies which stick to virus proteins but also stick to your own cells. The B cells are essentially permanent, that’s how you develop lasting immunity, that unfortunately also means you have lasting immunity on one of your own cell types — autoimmunity https://en.wikipedia.org/wiki/Autoimmune_disease